Business, neurology,  

Elekta to deliver latest brain radiosurgery system  to University of Virginia

Stockholm, Sweden. The University of Virginia Health System (U.Va.) will become one of the first centres in the world to install Elekta's (STO:EKTAB) new Leksell Gamma Knife Perfexion, the company's most advanced system for non-invasive radiosurgery for brain disorders. It is scheduled for installation in early spring 2007,

"We are very pleased with the assignment to equip one of the pioneering institutions in Gamma Knife surgery with this groundbreaking new system," said Tomas Puusepp, President and CEO of Elekta. "This order from University of Virginia, very shortly after receiving FDA clearance, demonstrates the value — both to patients and financially — that U.Va. has experienced with Gamma Knife surgery. We are looking forward to a continued close relationship with U.Va., and we also see a very strong interest in Leksell Gamma Knife Perfexion from other institutions, both in the U.S. and internationally," concluded Puusepp.

When U.Va. installed its first Leksell Gamma Knife in 1989, it became the fifth hospital in the world and the second in the USA to offer an alternative to open brain surgery. Since then, the U.Va. Gamma Knife Center has become a world leader in Gamma Knife surgery, now treating more than 600 patients a year.

Drawing upon its highly qualified team of neurosurgeons and pioneering work with Gamma Knife surgery, U.Va. offers an annual advanced training class in the clinical practice and research of Gamma Knife surgery for the treatment of AVMs, pituitary adenomas, acoustic neuromas and meningiomas.

The new system provides a platform for further refinement and expansion of radiosurgery procedures in the brain, cervical spine and head & neck regions.

Currently installed and in clinical operation at Hospital la Timone (University Hospital La Timone) in Marseille, France, the first patients were successfully treated with Leksell Gamma Knife Perfexion in mid July. In August, the U.S. Food and Drug Administration (FDA) issued a 510(k) pre-market clearance for Leksell Gamma Knife Perfexion, allowing Elekta (STO:EKTAB) to also market the new system in the U.S. market.

See also:

First patient treated with Elekta's new non-invasive radiotherapy system for brain tumours (July 2006)

To top

To top